Gabapentin for the Management of Chronic Pelvic Pain in Women (GaPP1): A Pilot Randomised Controlled Trial

Chronic pelvic pain (CPP) affects 2.1–24% of women. Frequently, no underlying pathology is identified, and the pain is difficult to manage. Gabapentin is prescribed for CPP despite no robust evidence of efficacy. We performed a pilot trial in two UK centres to inform the planning of a future multice...

Descripción completa

Detalles Bibliográficos
Autores principales: Lewis, Steff C., Bhattacharya, Siladitya, Wu, Olivia, Vincent, Katy, Jack, Stuart A., Critchley, Hilary O. D., Porter, Maureen A., Cranley, Denise, Wilson, John A., Horne, Andrew W.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2016
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4829183/
https://www.ncbi.nlm.nih.gov/pubmed/27070434
http://dx.doi.org/10.1371/journal.pone.0153037

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4829183/
https://www.ncbi.nlm.nih.gov/pubmed/27070434
http://dx.doi.org/10.1371/journal.pone.0153037

Ejemplares similares